Stock listing
NASDAQ:LBPH Longboard Pharmaceuticals Inc Stock
Follow Longboard Pharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:LBPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:LBPH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Longboard Pharmaceuticals Inc on 6ix
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 1, 2024
- Decks
- 9 decks · latest Aug 1, 2024
Events
| Call | When | Status |
|---|---|---|
| Longboard Pharmaceuticals (LBPH) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2024) | Investor deck | 32 slides | Aug 1, 2024 |
| Technical Presentation (June 2024) | Technical | 5 slides | Jun 10, 2024 |
| Investor Presentation (March 2024) | Investor deck | 41 slides | Mar 12, 2024 |
| Technical Presentation (January 2024) | Technical | 21 slides | Jan 2, 2024 |
| Investor Presentation (November 2023) | Investor deck | 50 slides | Nov 29, 2023 |
| Investor Day (October 2023) | Investor day | 49 slides | Oct 11, 2023 |
| Investor Presentation (December 2022) | Investor deck | 24 slides | Dec 5, 2022 |
| Investor Presentation (January 2022) | Investor deck | 33 slides | Jan 10, 2022 |
| Investor Presentation (December 2021) | Investor deck | 35 slides | Dec 1, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paul Sekhri Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past) | Director · Mar 11, 2021 – Dec 2, 2024 · Past |
| Brandi Roberts Other companies: Definium Therapeutics, Inc. (Chief Financial Officer · Since at least Jun 2, 2025); TFF Pharmaceuticals Inc (Director · Mar 25, 2022 – Jul 3, 2024 · Past); Lineage Cell Therapeutics, Inc. (CFO & SVP Finance · Jan 7, 2019 – Mar 17, 2020 · Past); Savara, Inc. (Chief Financial Officer & SVP · Jun 19, 2013 – Jan 20, 2017 · Past) | Executive VP and CFO · Mar 11, 2021 – Dec 2, 2024 · Past |
| Kevin Lind Other companies: Apnimed, Inc. (Chief Executive Officer · Since at least Jul 30, 2026); Avalo Therapeutics, Inc. (Director · Since at least Sep 22, 2025); Arena Pharmaceuticals Inc (Executive VP and CFO · Jun 15, 2016 – Mar 1, 2020 · Past) | President and CEO, Director · Mar 11, 2021 – Dec 2, 2024 · Past |
| Vincent Aurentz Other companies: Inhibikase Therapeutics, Inc. (Director · Since at least Feb 21, 2025); Arena Pharmaceuticals Inc (Executive VP and CBO · Aug 15, 2016 – Mar 11, 2022 · Past); EPIRUS Biopharmaceuticals Inc (Chief Business Officer · Nov 9, 2015 – May 27, 2016 · Past) | Director · Mar 11, 2021 – Dec 2, 2024 · Past |
| Casey Lynch Other companies: Quince Therapeutics, Inc. (Chief Executive Officer, Director · May 8, 2019 – Jan 3, 2022 · Past) | Director · Mar 11, 2021 – Dec 2, 2024 · Past |
| Jane Tiller | Director · Nov 15, 2021 – May 25, 2023 · Past |
| Philip Perera | CMO · Mar 11, 2021 – Feb 9, 2022 · Past |
Log in to ask 6ix AI your own questions about Longboard Pharmaceuticals Inc.